Literature DB >> 26374258

Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection.

S Pecere1, M Sabatelli2, M Fantoni3, G Ianiro1, A Gasbarrini1, G Cammarota4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26374258     DOI： 10.1111/apt.13362

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  7 in total

1.  Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.

Authors:  Monika Fischer; Brian Sipe; Yao-Wen Cheng; Emmalee Phelps; Nicholas Rogers; Sashidhar Sagi; Matthew Bohm; Huiping Xu; Zain Kassam
Journal:  Gut Microbes       Date:  2016-12-21

2.  Successful Therapy of Severe Pseudomembranous Clostridium difficile Colitis Using a Combination of Fecal Microbiota Therapy and Fidaxomicin.

Authors:  Peter C Konturek; Drilon Haziri; Harry Helfritzsch; Thomas Hess; Igor A Harsch
Journal:  Med Princ Pract       Date:  2016-12-15       Impact factor: 1.927

Review 3.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

Review 4.  Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation.

Authors:  Yvette H van Beurden; Max Nieuwdorp; Pablo J E J van de Berg; Chris J J Mulder; Abraham Goorhuis
Journal:  Therap Adv Gastroenterol       Date:  2017-02-08       Impact factor: 4.409

5.  Recent advances in the treatment of C. difficile using biotherapeutic agents.

Authors:  Vo Van Giau; Hyon Lee; Seong Soo A An; John Hulme
Journal:  Infect Drug Resist       Date:  2019-06-10       Impact factor: 4.003

Review 6.  Sleeping with the enemy: Clostridium difficile infection in the intensive care unit.

Authors:  Florian Prechter; Katrin Katzer; Michael Bauer; Andreas Stallmach
Journal:  Crit Care       Date:  2017-10-22       Impact factor: 9.097

7.  FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis.

Authors:  Jessica Mandrioli; Amedeo Amedei; Giovanni Cammarota; Elena Niccolai; Elisabetta Zucchi; Roberto D'Amico; Federica Ricci; Gianluca Quaranta; Teresa Spanu; Luca Masucci
Journal:  Front Neurol       Date:  2019-09-20       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.